Blis Technologies Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Blis Technologies Ltd with three other pharmaceutical manufacturers in Australasia: Regeneus Ltd of AUSTRALIA (2021 sales of 7.07 million Australian Dollars [US$5.27 million] ), Noxopharm Ltd of AUSTRALIA (5.75 million Australian Dollars [US$4.29 million] of which 100% was Clinical development), and Acrux Ltd which is also based in AUSTRALIA (4.79 million Australian Dollars [US$3.58 million] of which 100% was Developing and Commercialising products ).

Sales Analysis. During the year ended March of 2021, sales at Blis Technologies Ltd were 10.61 million New Zealand Dollars (US$7.59 million). This is a decrease of 0.3% versus 2020, when the company's sales were 10.64 million New Zealand Dollars.